Business
Sun Pharma Announces Appointment of Richard Ascroft as CEO North America
Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associated companies) announced the appointment of Richard Ascroft as its new North America Chief Executive Officer (CEO), effective June 16, 2025. Richard brings over three decades of experience in the pharmaceutical industry, with a proven record of leadership, innovation, and strategic growth.
About this update from Sun Pharmaceutical Industries Limited
[{"type":"text","content":"PRINCETON, N.J., June 25, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associated companies) announced the appointment of Richard Ascroft as its new North America Chief Executive Officer (CEO), effective June 16, 2025. Richard brings over three decades of experience in the pharmaceutical industry, with a proven record of leadership, innovation, and strategic growth.","length":509,"tagName":"p"},{"type":"image","alt":"Richard Ascroft, Sun Pharma North America CEO","displaySize":"","headline":null,"caption":"Richard Ascroft, Sun Pharma North America CEO","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":267,"url":"https://media.zenfs.com/en/prnewswire.com/f17b5bcef8cceb5d13758aa4dc41db16"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/QdRxvegpLQCnRgP5PvYlbw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ3MTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/f17b5bcef8cceb5d13758aa4dc41db16","width":400,"height":267}},"href":"https://mma.prnewswire.com/media/2718906/Sun_Pharma___Richard_Ascroft_Sun_Pharma_North_America_CEO.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"As North America CEO, Richard will advance Sun Pharma's diverse portfolio of innovative medicines, generics and over-the-counter products in both the U.S. and Canada. With a background spanning commercial, market access, clinical development and corporate affairs across the U.S. and global markets, Richard's expertise and vision will be instrumental in guiding the continued growth of the Sun Pharma North America business, including the innovative medicines portfolio which has upcoming commercial launches of new treatments for alopecia areata and squamous cell carcinoma.","length":589,"tagName":"p"},{"type":"text","content":""I am honored to join Sun Pharma as the North America CEO," said Richard Ascroft. "This is an exciting opportunity to lead a dynamic team committed to advancing Sun's portfolio of generic and innovative medicines. As Sun Pharma continues its growth trajectory, the North America region is poised to bring new treatments to the market and drive significant growth for the business. I look forward to building on our strong founda...